Figure8

Multicellular biomarkers of drug resistance as promising targets for glioma precision medicine and predictors of patient survival

Figure 8. Evaluation of the predictive performance of the identified signature in non-proneural type of GBM: (A) time-dependent ROC curves with corresponding AUCs at one and two years in training set (TCGA, $$ n = $$ 127); and (B) time-dependent ROC curves with corresponding AUCs at one and two years in testing set (CGGA, $$ n = $$ 108). GBM: glioblastoma multiforme. TCGA: The Cancer Genome Atlas. ROC: receiver operating characteristic.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/